Academic Exchanges
-
Academic Trends | The Latest Achievements of the Transplantation Team in Beijing Boren Hospital Show Up at the 23rd Asia-Pacific Blood and Marrow Transplantation Conference
Following one keynote speech and three poster reports at the 15th National Academic Conference of Hematology, Beijing Boren Hospital once again brought outstanding academic achievements to the 23rd …
2019-08-08 -
Director Chunrong TONG from Our Hospital Gave a Speech at the 2018 International Conference on Cellular Immunotherapy in Zhoushan
The world's breakthrough in the field of cellular immunotherapy has become a hot topic. On April 19-20 this year, the 2018 International Conference on Cellular Immunotherapy, i.e., the Seminar o…
2019-08-08 -
Interview with Director Chunrong TONG: We Have Entered A New Era of Immunotherapy And Targeted Therapy For Hematologic Malignancies
Introduction: Director Chunrong TONG from Beijing Boren Hospital shared the achievements and experience in the CART therapies for refractory/relapsed hematological malignancies in Beijing Boren Hosp…
2019-08-08 -
On behalf of Beijing Boren Hospital, Director Jing PAN Spoke at the Annual Conference of the European Hematology Association and Was Interviewed by International Media
(June 16, live report in Stockholm) On behalf of Beijing Boren Hospital, Director Jing PAN in the Department of Hematology in our hospital delivered a speech at the 23rd annual conference of the Eur…
2019-08-08 -
Two Papers for Leukemia in Two Years! Chunrong TONG and Jing PAN's Team's New Breakthrough in CD22 CAR-T Cell Therapy for Relapsed and Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL)
Dr. Jing PAN's team's research paper “CD22 CAR-T cell therapy in refractory or relapsed B acute lymphoblastic leukemia” was officially included and published in Leukemia, the world's t…
2019-08-08 -
PPSSC Newsletter Director Chunrong TONG and Director Tong WU Were Invited to Attend the 12th Pan Pacific Symposium on Stem Cells and Cancer Research and Gave a Keynote Speech
PPSSC Newsletter Director Chunrong TONG and Director Tong WU Were Invited to Attend the 12th Pan Pacific Symposium on Stem Cells and Cancer Research and Gave a Keynote Speech(May 4, Taiwan, China) T…
2019-08-08 -
ICML2019︱Professor Yonghong ZHANG's Team Cheers Up for The Findings on CAR-T Therapy for Refractory and Relapsed Burkitt's Lymphoma in Children
ICML2019︱Professor Yonghong ZHANG's Team Cheers Up for The Findings on CAR-T Therapy for Refractory and Relapsed Burkitt's Lymphoma in Children(June 19, Lugano, Switzerland) The 15th Internat…
2019-08-08 -
EHA News 4 Research Achievements Unveiled at The Global Hematology Event, New Hope for Patients with Hematological Malignancies
On June 13-16, the 24th Conference of the European Hematology Association (EHA 2019) is being held in Amsterdam, the Netherlands. This event is hosted by the European Hematology Association (EHA), a…
2019-08-08 -
EBMT Voice of China | Beijing Boren Hospital Appears at the 45th Annual Conference of the European Society for Blood and Marrow Transplantation with Distinction
(March 27, Frankfurt, Germany) The 45th Annual Conference of the European Society for Blood and Marrow Transplantation (EBMT 2019) is being held at the Congress Center Messe Frankfurt, and it is one…
2019-08-08 -
CD22 CAR-T Cell Therapy Brings New Hope for Efficacy
On behalf of Beijing Boren Hospital, Director Jing PAN in the Department of Hematology in our hospital delivered a speech at the 23rd annual conference of the European Hematology Association (EHA) h…
2019-08-08 -
ASH Newsletter Director Shuangyou LIU, on behalf of Beijing Boren Hospital, reported that sequential CD19- and CD22-CART cell therapies achieved a relapse-free survival rate up to 68.8% in the treatment of relapsed B-ALL after transplantation
(December 1, San Diego, California, USA) The 60th Annual Conference of the American Society of Hematology (ASH) was held in San Diego, California, USA. This is the annual event in the global hematol…
2019-08-08 -
[2018 EHA On-site Express] Dr. Jing PAN's Oral Presentation: In CAR-T Cell Therapy, CD22-CAR-T Cells Take the Lead!
On June 14-17, 2018, the 23rd EHA conference was held in Stockholm, Sweden, and the key studies in the field of hematology were presented. In the conference, Dr. Jing PAN from Beijing Boren Hospital…
2019-08-08
